These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 8922728)
1. Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells. Scuntaro I; Kientsch U; Wiesmann UN; Honegger UE Br J Pharmacol; 1996 Nov; 119(5):829-34. PubMed ID: 8922728 [TBL] [Abstract][Full Text] [Related]
2. Alpha-tocopherol influences the lipid membrane affinity of desipramine in a pH-dependent manner. Marenchino M; Alpstäg-Wöhrle AL; Christen B; Wunderli-Allenspach H; Krämer SD Eur J Pharm Sci; 2004 Feb; 21(2-3):313-21. PubMed ID: 14757504 [TBL] [Abstract][Full Text] [Related]
3. Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells. Honegger UE; Scuntaro I; Wiesmann UN Biochem Pharmacol; 1995 Jun; 49(12):1741-5. PubMed ID: 7598736 [TBL] [Abstract][Full Text] [Related]
4. Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Consequences of drug accumulation on cellular lipid metabolism and plasma membrane properties of chronically exposed cells. Honegger UE; Zuehlke RD; Scuntaro I; Schaefer MH; Toplak H; Wiesmann UN Biochem Pharmacol; 1993 Jan; 45(2):349-56. PubMed ID: 8382061 [TBL] [Abstract][Full Text] [Related]
5. A role for lysosomal phospholipase A2 in drug induced phospholipidosis. Abe A; Hiraoka M; Shayman JA Drug Metab Lett; 2007 Jan; 1(1):49-53. PubMed ID: 19356018 [TBL] [Abstract][Full Text] [Related]
6. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes. Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403 [TBL] [Abstract][Full Text] [Related]
7. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect. Pauluhn J Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122 [TBL] [Abstract][Full Text] [Related]
9. Drug-induced phospholipidosis: are there functional consequences? Reasor MJ; Kacew S Exp Biol Med (Maywood); 2001 Oct; 226(9):825-30. PubMed ID: 11568304 [TBL] [Abstract][Full Text] [Related]
10. Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. Honegger UE; Roscher AA; Wiesmann UN J Pharmacol Exp Ther; 1983 May; 225(2):436-41. PubMed ID: 6221090 [TBL] [Abstract][Full Text] [Related]
11. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone. Natale A; Boeckmans J; Desmae T; De Boe V; De Kock J; Vanhaecke T; Rogiers V; Rodrigues RM Toxicol Lett; 2018 Mar; 284():184-194. PubMed ID: 29248575 [TBL] [Abstract][Full Text] [Related]
12. Vitamin E reduces antidepressant-related beta-adrenoceptor down-regulation in cultured cells. Comparable effects on St. John's wort and tricyclic antidepressant treatment. De Marchis GM; Bürgi S; Kientsch U; Honegger UE Planta Med; 2006 Dec; 72(15):1436-7. PubMed ID: 17109256 [TBL] [Abstract][Full Text] [Related]
13. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk. Okamoto H; Hamaguchi R; Kuroda Y J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021 [TBL] [Abstract][Full Text] [Related]
14. Derivatization of common antidepressant drugs increases inhibition of acid sphingomyelinase and reduces induction of phospholipidosis. Rhein C; Löber S; Gmeiner P; Gulbins E; Tripal P; Kornhuber J J Neural Transm (Vienna); 2018 Dec; 125(12):1837-1845. PubMed ID: 30191367 [TBL] [Abstract][Full Text] [Related]
16. Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats. Agoston M; Orsi F; Fehér E; Hagymási K; Orosz Z; Blázovics A; Fehér J; Vereckei A Toxicology; 2003 Aug; 190(3):231-41. PubMed ID: 12927377 [TBL] [Abstract][Full Text] [Related]
17. Human fibroblast cultures as a tool for the study of antidepressant drug action. Honegger UE Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):59-65. PubMed ID: 2431473 [TBL] [Abstract][Full Text] [Related]
18. Cellular accumulation and lipid binding of perfluorinated alkylated substances (PFASs) - A comparison with lysosomotropic drugs. Sanchez Garcia D; Sjödin M; Hellstrandh M; Norinder U; Nikiforova V; Lindberg J; Wincent E; Bergman Å; Cotgreave I; Munic Kos V Chem Biol Interact; 2018 Feb; 281():1-10. PubMed ID: 29248446 [TBL] [Abstract][Full Text] [Related]
19. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier. Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220 [TBL] [Abstract][Full Text] [Related]
20. Antidepressant-induced lipidosis with special reference to tricyclic compounds. Xia Z; Ying G; Hansson AL; Karlsson H; Xie Y; Bergstrand A; DePierre JW; Nässberger L Prog Neurobiol; 2000 Apr; 60(6):501-12. PubMed ID: 10739086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]